Iomeron (Iomeprol)

Iomeprol contains iodine atoms that strongly absorb X‑ray photons. When injected, the iodine increases the radiodensity of the area where it circulates, creating a contrast between enhanced structures and surrounding tissues. This differential attenuation allows imaging systems to produce sharper, more detailed pictures of anatomical features.

The specific dose of Iomeron is determined by the prescribing physician based on the type of imaging study, patient size, renal function, and clinical protocol. Healthcare professionals calculate the appropriate volume to achieve optimal contrast while minimizing risk.

The safety of Iomeron in pregnancy and lactation has not been definitively established. It should be used only if clearly needed and after careful risk‑benefit assessment by the treating physician. Breastfeeding mothers should discuss potential exposure with their healthcare provider.

To request Iomeron, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Iomeron (Iomeprol) is a low‑osmolar, non‑ionic iodinated contrast medium offering high iodine concentration (350 mg I/mL) and good tolerability. Compared with older high‑osmolar agents, it generally produces fewer discomfort reactions and a lower incidence of renal adverse effects, while providing comparable image quality.

Iomeron should be stored at ambient temperature, preferably below 25 °C, in its original sealed container. Protect the solution from direct sunlight, moisture, and extreme temperature fluctuations. Do not freeze or shake the vial before use.

Iomeron is supplied as a sterile solution for injection and is administered by a qualified healthcare professional via intraarterial, intraarticular, or intrathecal routes, depending on the imaging procedure. The injection is typically performed under aseptic conditions using appropriate catheters or needles.

The most serious risks include severe allergic reactions such as anaphylaxis, acute renal impairment especially in patients with pre‑existing kidney disease, hypotension or cardiovascular collapse, and rare pulmonary edema. Immediate medical attention is required if any of these events occur.

Iomeron should be avoided in patients with a known hypersensitivity to iodinated contrast media, those with uncontrolled severe asthma, or individuals with significant renal insufficiency where alternative imaging strategies are feasible. The prescribing clinician must evaluate each patient’s medical history before use.